Cart - OncoTAb

Your cart is currently empty.

Return To Shop

Get Your

Agkura™ Personal Score

Click Here

Targeting BRAFV600 in Glioblastoma
Is it time to perform NGS testing for all brain tumors?
Do Your Part to Aid in the Fight Against Cancer
Cancer is a leading cause of death in the United States and throughout the world.
Fyarro for Malignant Perivascular Epithelioid Cell Tumor (PEComa)
The U.S. Food and Drug Administration (FDA) has approved FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for intravenous use for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).
LYT-200
Pancreatic Cancer - Cholangiocarcinoma Clinical Trial
Bemcentinib - Keytruda Combination in NSCLC
FDA Grants Fast Track Designation to Bemcentinib Combo in Advanced NSCLC
Movember
by Dr. C.H. Weaver 11/2021 It's “Movember” again - the annual event involving the growing of mustaches to raise awareness of men's health issues including prostate cancer, testicular cancer, and men's suicide is in full force. Cancer Connect salutes the Movember movement and has assembled the ...
Ask Dr. Charu Aggarwal About the Management of Lung Cancer
Ask The Expert:Dr Aggarwal - University of Pennsylvania answered your questions about Lung Cancer
Ask the Expert About Advanced Lung Cancer
Dana-Farber Cancer Institute’s Dr. Jackman M. D. discusses the latest advances in the management of lung cancer
The NCBC on American Cancer Society’s Breast Cancer Screening Recommendations
The National Consortium of Breast Centers (NCBC) on American Cancer Society’s Breast Cancer Screening Recommendations
Imfinzi Plus Chemotherapy Improves Survival in Advanced Biliary Tract Cancers
Immunotherapy improves survival in cholangiocarcinoma and other biliary tract cancers.

Get Your

Agkura™ Personal Score

NEWSLETTER

LINKS

ADDRESS

PHONE

EMAIL

Get Your

Agkura™ Personal Score

NEWSLETTER

SOCIAL MEDIA

LINKS

ADDRESS

PHONE

EMAIL